Pharma Company Makes Jaw Dropping Admission About COVID Vax

The stunning admission took place in court and it is the first time one of the major pharmaceutical companies had made such a statement.

Some massive lawsuits are going on in the UK surrounding the Astra Zeneca COVID vaccine and it’s quickly becoming and international story.

From the Telegraph:

AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause a rare side effect, in an apparent about-turn that could pave the way for a multi-million pound legal payout.

The pharmaceutical giant is being sued in a class action over claims that its vaccine, developed with the University of Oxford, caused death and serious injury in dozens of cases.

Lawyers argue the vaccine produced a side effect which has had a devastating effect on a small number of families.

The first case was lodged last year by Jamie Scott, a father of two, who was left with a permanent brain injury after developing a blood clot and a bleed on the brain that has prevented him from working after he received the vaccine in April 2021. The hospital called his wife three times to tell her that her husband was going to die.

AstraZeneca is pushing back on the claims; however, in February, it admitted that the COVID vaccine “can, in very rare cases, cause TTS.”

TTS stands for Thrombosis with Thrombocytopenia syndrome which causes people to have blood clots.

In May of 2023, Astrazeneca lawyers said, “we do not accept that TTS is caused by the vaccine at a generic level.”

Now they are admitting “that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known. Further, TTS can also occur in the absence of the AZ vaccine (or any vaccine). Causation in any individual case will be a matter for expert evidence.”

The issue with the vaccine was discovered as early as March 2021.

The UK government did indemnify AstraZenece from legal action but as of the writing of this post is not intervening in the legal proceedings.



Please enter your comment!
Please enter your name here